Johnson & Johnson, AstraZeneca and GlaxoSmithKline are among 10 pharmaceutical companies that are jointly leveraging data insights to accelerate drug discovery, development and go-to-market times while reducing costs. It is just one example of how companies are starting to use federated learning, a machine learning framework that allows artificial intelligence algorithms to learn from data distributed across multiple locations and owners, without the need to share sensitive data directly.
This article is part of The Innovator’s premium content offer and available only to The Innovator’s Radar subscribers.
If you are already a Radar subscriber click here to sign into your account.
For a free trial Radar Subscription click here.
